Memory & Recall
Strengthen encoding, retention, and retrieval
Improved short-term and long-term memory consolidation
Estimated Monthly Cost
$58
Ingredients
4
Why These Combine
This stack is built around one honest constraint: the only compound here with a positive meta-analysis for memory in healthy adults is Bacopa, and it needs 12 weeks of daily dosing before that shows up. Everything else plays a supporting role on a different timescale. Alpha-GPC supplies choline so acetylcholine synthesis is not the limiting step during encoding. Lion's Mane targets the slower neurotrophic path — its one good human trial ran 16 weeks and the benefit faded within 4 weeks of stopping, which tells you this is maintenance, not a one-off. Phosphatidylserine sits in the evening slot for membrane support and to avoid stacking two morning stimulant-adjacent compounds. If you want something you can feel this week, this is the wrong stack; the evidence here is for consistent use measured in months. Two numbers put the supporting compounds in proportion. The alpha-GPC trial most often quoted gave 1,200 mg a day (400 mg three times daily) for 180 days to 261 patients with mild-to-moderate Alzheimer's dementia, where the ADAS-Cog score improved by 3.20 points while the placebo group worsened by 2.90 (De Jesus Moreno 2003) — four times the dose here, in a clinical population, and there is no comparable trial in healthy adults. For phosphatidylserine, 78 Japanese adults aged 50–69 with memory complaints took 100 or 300 mg of soy-derived PS a day for six months: the whole-group scores did not separate from placebo, and the gain in delayed verbal recall appeared only in those with low baseline scores (Kato-Kataoka 2010). The Bacopa meta-analysis itself is modest — across 437 analysed participants the gains were 17.9 ms on Trail B and 10.6 ms on choice reaction time, which is speed of attention: measurable, not transformative. Compared with the Student Study stack, this one drops L-theanine and creatine (the parts you feel in a single session) and adds alpha-GPC and phosphatidylserine for a longer horizon; the Advanced Nootropic stack goes further and adds noopept, which is not a dietary supplement in the US or EU. Verdict: a reasonable twelve-week trial for someone whose complaint is recall rather than concentration, with the honest expectation of a small, slow effect.
- Exam season rather than long-term recall? The Student Study stack keeps the bacopa and adds what you feel in a session→
- Why bacopa takes twelve weeks, and how to run a fair trial on yourself — Bacopa Dosage and Timeline→
- The Advanced Nootropic stack adds noopept — read its safety section before considering it→
Full Ingredient Protocol
Meta-analysis of 9 RCTs (518 participants, 12 weeks or longer): faster Trail B and choice reaction time (Kongkeaw 2014). Nothing shows before week 8
Choline donor. Its memory evidence is 1,200 mg/day for 180 days in Alzheimer's dementia (De Jesus Moreno 2003) — four times this dose, in a clinical population
Membrane phospholipid. 100–300 mg/day for 6 months improved delayed recall only in older adults with low baseline scores (Kato-Kataoka 2010)
The NGF mechanism is preclinical; the one controlled trial used 3 g/day for 16 weeks in mild cognitive impairment and the gain faded after stopping (Mori 2009)
Disclaimer
Informational only — not medical advice. Bacopa needs 8–12 weeks of daily dosing before its effect shows up, so judge this stack in months, not days; take it with a fatty meal, because on an empty stomach it commonly causes nausea, and check with your doctor if you are on thyroid or sedative medication. Alpha-GPC may lower blood pressure — start low if you already take antihypertensives. Lion's Mane is a mushroom: avoid it if you have a mushroom allergy. Phosphatidylserine is usually soy-derived and may add to blood-thinning medication. None of these four has adequate pregnancy or breastfeeding safety data, which is not the same as being safe.
Partner offers
Paid placements. We earn a commission if you buy through these links, at no extra cost to you — it does not change what we write. These are the seller’s own products and claims, not ours, and nothing here is medical advice. Speak to a clinician before starting any supplement.
References
- 1.Kongkeaw 2014, J Ethnopharmacol — Meta-analysis of 9 randomised placebo-controlled trials (518 participants) of standardised Bacopa monnieri extract, restricted to chronic dosing of 12 weeks or more with no co-medication. Across 437 analysed participants: Trail B shortened by 17.9 ms (95% CI −24.6 to −11.2) and choice reaction time by 10.6 ms. This 12-week floor is why the stack is described in months rather than days.
- 2.De Jesus Moreno 2003, Clin Ther — 261 patients with mild-to-moderate Alzheimer's dementia (mean age 72), multicentre double-blind: choline alfoscerate (alpha-GPC) 400 mg three times daily for 180 days improved ADAS-Cog by 3.20 points while placebo worsened by 2.90; MMSE, GDS and CGI also separated from placebo. (clinical population at four times the dose used here)
- 3.Kato-Kataoka 2010, J Clin Biochem Nutr — 78 Japanese adults aged 50–69 with memory complaints, double-blind: soy-derived phosphatidylserine 100 or 300 mg/day for 6 months. Neuropsychological scores rose in all groups including placebo; only participants with low baseline scores improved against baseline on PS, mainly in delayed verbal recall. No side effects observed. (subgroup finding; the primary comparison with placebo was null)
- 4.Mori 2009, Phytother Res — Double-blind placebo-controlled trial in 30 adults aged 50–80 with mild cognitive impairment: 3 g/day Hericium erinaceus for 16 weeks significantly improved cognitive-scale scores at weeks 8, 12 and 16 — but scores fell significantly 4 weeks after stopping. Benefit depends on continued intake. (small (n=30) and in an impaired population, not healthy adults)
